Compare · EW vs PII
EW vs PII
Side-by-side comparison of Edwards Lifesciences Corporation (EW) and Polaris Inc. (PII): market cap, price performance, sector, and recent activity on the wire.
Summary
- EW operates in Health Care, while PII operates in Consumer Discretionary - the two are in different parts of the market.
- EW is the larger of the two at $50.78B, about 16.7x PII ($3.04B).
- Over the past year, EW is up 16.0% and PII is down 21.5% - EW leads by 37.6 points.
- PII has been more active in the news (8 items in the past 4 weeks vs 5 for EW).
- Both have 25 recent analyst ratings on file.
- Company
- Edwards Lifesciences Corporation
- Polaris Inc.
- Price
- $86.61-1.66%
- $52.17-2.39%
- Market cap
- $50.78B
- $3.04B
- 1M return
- -1.84%
- -6.39%
- 1Y return
- +16.04%
- -21.52%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NYSE
- IPO
- News (4w)
- 5
- 8
- Recent ratings
- 25
- 25
Edwards Lifesciences Corporation
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Polaris Inc.
Polaris Inc. designs, engineers, manufactures, and markets power sports vehicles worldwide. It operates in five segments: ORV/Snowmobiles, Motorcycles, Global Adjacent Markets, Aftermarket, and Boats. The company offers off-road vehicles (ORVs), including all-terrain vehicles and side-by-side vehicles; snowmobiles and snow bikes conversion kit systems; motorcycles; and low emission, light duty hauling, passenger, and industrial vehicles. It also produces replacement parts and accessories comprising winches, bumper/brushguards, plows, racks, wheels and tires, pull-behinds, cab systems, lighting and audio systems, cargo box accessories, tracks, and oil for ORVs; snowmobile accessories, which comprise covers, traction products, electric starters, reverse kits, tracks, bags, windshields, oil, and lubricants; and motorcycle accessories, including e saddle bags, handlebars, backrests, exhausts, windshields, seats, oil, and various chrome accessories. In addition, the company offers gear and apparel, such as helmets, jackets, gloves, pants, hats, goggles, boots, bibs, and leathers; off-road Jeep and truck accessories; and pontoon and deck boats. The company provides its products through dealers and distributors, and online; and aftermarket parts and accessories through 95 brick-and-mortar retail centers, call centers, and e-commerce sites. The company was formerly known as Polaris Industries Inc. Polaris Inc. was founded in 1954 and is headquartered in Medina, Minnesota.
Latest EW
- SEC Form 4 filed by Edwards Lifesciences Corporation
- Barclays initiated coverage on Edwards Lifesciences with a new price target
- Edwards Lifesciences to Host Earnings Conference Call on November 4, 2026
- Edwards Lifesciences to Host Investor Event in Conjunction With TCT
- Edwards Lifesciences Receives FDA Approval for AUTUS Valve, the First Surgical Pulmonary Valve for Pediatric Patients
- SVP, Corporate Controller Dahl Andrew M. covered exercise/tax liability with 253 shares, decreasing direct ownership by 2% to 14,615 units (SEC Form 4) to satisfy withholding tax
- CVP, JAPAC Markowitz Wayne covered exercise/tax liability with 923 shares, decreasing direct ownership by 5% to 19,371 units (SEC Form 4) to satisfy tax liability
- CVP, TAVR Lippis Daniel J. exercised 619 shares at a strike of $72.68 and sold $54,169 worth of shares (619 units at $87.51) as part of a pre-agreed trading plan (SEC Form 4)
- CVP, TMTT, Surgical & IHFM Chopra Daveen covered exercise/tax liability with 398 shares, decreasing direct ownership by 0.90% to 43,926 units (SEC Form 4) to satisfy tax liability
- Edwards Lifesciences Comments on TAVR National Coverage Decision
Latest PII
- GODFREY PONTOON BOATS REIMAGINES SPORT LUXURY WITH THE ALL-NEW 2027 AQUAPATIO
- Polaris Schedules Third Quarter 2026 Earnings Conference Call and Webcast
- Director Shotwell Gwynne was granted 609 shares, increasing direct ownership by 2% to 30,441 units (SEC Form 4)
- Director Semach Dustin J. was granted 633 shares, increasing direct ownership by 108% to 1,219 units (SEC Form 4)
- Director Kessler Bernd F was granted 656 shares, increasing direct ownership by 1% to 64,242 units (SEC Form 4)
- Director Henricks Gwenne A. was granted 609 shares, increasing direct ownership by 1% to 41,863 units (SEC Form 4)
- Director Hendrickson Gary E was granted 609 shares, increasing direct ownership by 1.00% to 61,479 units (SEC Form 4)
- Director Bilicic George W was granted 692 shares, increasing direct ownership by 2% to 39,169 units (SEC Form 4)
- BENNINGTON PONTOONS CELEBRATES 30 YEARS WITH ITS MOST CAPABLE AND PERSONALIZED PONTOON LINEUP YET
- WAYNE MATLOCK WINS SCORE BAJA 400 IN POLARIS RZR PRO R FACTORY, CLAIMS $50,000 POLARIS SCORE CHALLENGE